Frontiers in Immunology, 2024 Refined innate plasma signature after rVSVΔG-ZEBOV-GP immunization is shared among adult cohorts in Europe and North America Martinez-Murillo P., Huttner A., Lemeille S. et al. Olink Target 96Immunological & Inflammatory DiseasesInfectious DiseasesPatient StratificationPlasma | | | | |
Nature Communications, 2024 BCG vaccination-induced acquired control of mycobacterial growth differs from growth control preexisting to BCG vaccination van Meijgaarden K., Li W., Moorlag S. et al. Olink Target 96Infectious DiseasesPathophysiologyPlasma | | | | |
Nature Biotechnology, 2024 Discovery of sparse, reliable omic biomarkers with Stabl Hédou J., Marić I., Bellan G. et al. Olink Explore 3072/384Wider Bioinformatics StudiesData SciencePlasma | | | | |
European Journal of Pain, 2023 Exploring biomarkers in trigeminal neuralgia patients operated with microvascular decompression: A comparison with multiple sclerosis patients and non‐neurological controls Lafta M., Sokolov A., Landtblom A. et al. Olink Target 96NeurologyPathophysiologyPatient StratificationSerumCSF | | | | |
Clinical Oral Investigations, 2023 Targeted proteomics in a population-based study identifies serum PECAM-1 and TRIM21 as inflammation markers for periodontitis Reckelkamm S., Kamińska I., Baumeister S. et al. Olink Target 96Other Diseases & SyndromesPathophysiologySerum | | | | |
JAMA Cardiology, 2023 Variants at the Interleukin 1 Gene Locus and Pericarditis Thorolfsdottir R., Jonsdottir A., Sveinbjornsson G. et al. Olink Explore 3072/384CVDPathophysiologyPlasma | | | | |
Journal of Crohn's and Colitis, 2023 Baseline Serum and Stool Microbiome Biomarkers Predict Clinical Efficacy and Tissue Molecular Response After Ritlecitinib Induction Therapy in Ulcerative Colitis Hassan-Zahraee M., Ye Z., Xi L. et al. Olink Explore 3072/384Immunological & Inflammatory DiseasesPatient StratificationSerumTissue Lysate | | | | |
Annals of Medicine, 2023 Elevated soluble LOX-1 predicts risk of first-time myocardial infarction Schiopu A., Björkbacka H., Narasimhan G. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
International Journal of Obesity, 2023 Sex-specific association of visceral and subcutaneous adipose tissue volumes with systemic inflammation and innate immune cells in people living with obesity van den Munckhof I., Bahrar H., Schraa K. et al. Olink Target 96Metabolic DiseasesPathophysiologyPlasma | | | | |
Biomarkers, 2023 Relationships between Charlson comorbidity index associated biomarkers and outcomes among participants in the Malmö diet and cancer study Wessman T., Ruge T., Carlsson A. et al. Olink Target 96CVDPatient StratificationSerum | | | | |
British Journal of Cancer, 2023 The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk Grassmann F., Mälarstig A., Dahl L. et al. Olink Target 96OncologyPatient StratificationPlasma | | | | |
Open Heart, 2023 Women have less progression of paroxysmal atrial fibrillation: data from the RACE V study Mulder B., Khalilian Ekrami N., Van De Lande M. et al. Olink Target 96CVDPathophysiologyPlasma | | | | |
International Journal of Cardiology, 2023 Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF Adamo M., Pagnesi M., Di Pasquale M. et al. Olink Target 96CVDPathophysiologyPatient StratificationPlasma | | | | |
British Journal of Cancer, 2023 Associations of diabetes, circulating protein biomarkers, and risk of pancreatic cancer Pang Y., Lv J., Wu T. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
International Journal of Molecular Sciences, 2023 The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis Gaetani L., Bellomo G., Di Sabatino E. et al. Olink Target 96NeurologyPatient StratificationCSF | | | | |
Human Gene Therapy, 2023 Prophylactic Prednisolone Promotes AAV5 Hepatocyte Transduction Through the Novel Mechanism of AAV5 Coreceptor Platelet-Derived Growth Factor Receptor Alpha Upregulation and Innate Immune Suppression Handyside B., Zhang L., Yates B. et al. Olink Target 96 MouseImmunological & Inflammatory DiseasesTechnical EvaluationPlasma | | | | |
Environmental Toxicology and Pharmacology, 2023 Inflammation-related proteins in blood after dermal exposure to some common chemicals depend on the skin barrier gene filaggrin - a human experimental study Liljedahl E., Gliga A., de Paula H. et al. Olink Target 96Environmental Health & ToxicologyPathophysiologySerum | | | | |
Blood Advances, 2023 A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204) Phillips T., Avigdor A., Gurion R. et al. Olink Target 96OncologyPathophysiologySerum | | | | |
International Journal of Molecular Sciences, 2023 Parasite DNA and Markers of Decreased Immune Activation Associate Prospectively with Cardiac Functional Decline over 10 Years among Trypanosoma cruzi Seropositive Individuals in Brazil Sunderraj A., Cunha L., Avila M. et al. Olink Explore 3072/384CVDInfectious DiseasesPathophysiologySerum | | | | |
Cancer Research Communications, 2023 Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study Munster P., Iannotti N., Cho D. et al. Olink Target 96OncologyImmunotherapyPathophysiologyPlasma | | | | |